Summary of medicine characteristics - Evalon
SUMMARY OF PRODUCT CHARACTERISTICS
-
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Evalon suspension and solvent for oral spray for chickens.
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Evalon:
Each dose (0.007 ml) of undiluted vaccine contains:
Active substances:
-
* Number of sporulated oocysts derived from precocious attenuated lines of coccidia, according to in vitro procedures of the manufacturer at the time of blending.
HIPRAMUNE T (solvent):
Adjuvant:
Montanide IMS
Excipients:
Brilliant Blue (E133)
Red AC (E129)
Vanillin
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Suspension and solvent for oral spray. Suspension: White turbid suspension. Solvent: Dark brownish solution.
4. CLINICAL PARTICULARS4.1 Target species
Chickens.
-
4.2 Indications for use, specifying the target species
For active immunisation of chicks from 1 day of age to reduce clinical signs (diarrhoea), intestinal lesions and oocysts output associated with coccidiosis caused by Eimeria acervulina , Eimeria brunetti, Eimeria maxima, Eimeria necatrix and Eimeria tenella.
Onset of immunity: 3 weeks post-vaccination.
Duration of immunity: 60 weeks post-vaccination in an environment that permits oocysts recycling.
4.3 Contraindications
None.
-
4.4 Special warnings for each target species
Vaccinate healthy animals only.
The vaccine will not protect species other than chickens against coccidiosis and is only effective against the Eimeria species indicated.
It is normal to find vaccinal oocysts in the intestine or litter of vaccinated flocks. Generally the number is higher the first weeks post-vaccination and lower once the flock has achieved a proper protection.
-
4.5 Special precautions for use
Special precautions for use in animals
Chickens must be strictly floor-reared in the first 3 weeks after vaccination.
It is recommended that litter should be removed and facilities and material cleaned between production cycles to reduce field infections.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Wash and disinfect hands and equipment after use.
-
4.6 Adverse reactions (frequency and seriousness)
None.
-
4.7 Use during pregnancy, lactation or lay
The safety of the veterinary medicinal product has not been established during lay. Do not use in birds in lay and within 2 weeks before the onset of the laying period.
4.8 Interaction with other medicinal products and other forms of interaction
No information is available on the safety and efficacy of this immunological veterinary medicinal product when used with any other veterinary medicinal product. A decision to use this immunological veterinary medicinal product before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
No anticoccidial substances or other agents having anticoccidial activity via feed or water should be used for at least 3 weeks following vaccination of the chickens. The correct replication of the vaccine oocysts and consequently, the development of a solid immunity could be hindered. Additionally, the enhancement of protection produced by oocyst re-infections would also be limited.
-
4.9 Amounts to be administered and administration route
Oral use.
The method of administration is by coarse spray.
Vaccination schedule:
One dose of vaccine (0.007 ml) from 1 day of age.
Administration route:
The method of administration is by coarse spray by using a suitable device (volume delivered:
28 ml/100 chicks, droplet size: 200–250 ^m and working pressure: 2 to 3 bars). Before starting the preparation, make certain to have a clean container available with sufficient capacity for preparing the diluted vaccine suspension. Dilute the vaccine with the corresponding volumes:
| Doses | Water | Vaccine | Solvent | Total |
| 1,000 | 223 ml | 7 ml | 50 ml | 280 ml |
| 5,000 | 1,115 ml | 35 ml | 250 ml | 1,400 ml |
| 10,000 | 2,230 ml | 70 ml | 500 ml | 2,800 ml |
Shake the solvent vial. Dilute the content of the vial with clean room temperature water into an appropriate container.
Shake the vaccine vial and dilute the content into the previous solution.
Fill the reservoir of the spraying device with all the vaccine suspension prepared.
Maintain the diluted vaccine suspension in continuous homogenisation by using a magnetic stirrer while the vaccine is being administered via coarse spray to the chicks.
To improve the uniformity of the vaccination maintain the chicks inside the transportation box for at least 1 hour in order to let them ingest all the vaccine droplets.
After this time, place the chicks carefully in the litter and continue with regular management practices.
The device should be cleaned after each use. See the manufacturer’s instructions to ensure proper disinfection and maintenance of the device.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Severe overdose (10-fold) may result in a temporary reduction in daily live weight gain within the first week without any consequences on the final performances.
-
4.11 Withdrawal period(s)
Zero days.
-
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: Immunological for Aves, live parasitic vaccines for domestic fowl. ATC vet code: QI01AN01.
To stimulate active immunity against coccidiosis caused by Eimeria acervulina , Eimeria brunetti, Eimeria maxima, Eimeria necatrix and Eimeria tenella.
6. PHARMACEUTICAL PARTICULARS6.1 List of excipients
Evalon (vaccine)
Phosphate buffered solution (PBS):
-
– Potassium chloride
-
– Disodium phosphate dodecahydrate
-
– Potassium dihydrogen phosphate
-
– Sodium chloride
HIPRAMUNE T (solvent)
-
– Brilliant blue (E 133)
-
– Red AC (E 129)
-
– Vanillin
-
– Montanide IMS
6.2 Major incompatibilities
Do not mix with any other veterinary medicinal product, except the solvent supplied for use with the veterinary medicinal product.
6.3 Shelf life
Evalon (vaccine):
Shelf life of the veterinary medicinal product as packaged for sale: 10 months.
Shelf life after first opening the immediate packaging: use immediately.
Shelf life after dilution according to directions: 10 hours.
HIPRAMUNE T (solvent):
Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
6.4. Special precautions for storage
Store and transport refrigerated (2 °C-8 °C).
Do not freeze.
-
6.5 Nature and composition of immediate packaging
Evalon (vaccine)
10 ml, 50 ml or 100 ml type I colourless glass vials containing 7 ml, 35 ml or 70 ml of suspension (1,000, 5,000 and 10,000 doses) closed with type I polymeric elastomer closures and aluminium caps.
HIPRAMUNE T (solvent)
Polypropylene (PP) vials containing 50 ml, 250 ml and 500 ml of solvent closed with type I polymeric elastomer closures and aluminium caps.
Pack sizes
Cardboard box with one vial of 1,000 doses (7 ml) and one vial with 50 ml of solvent.
Cardboard box with one vial of 5,000 doses (35 ml) and one vial with 250 ml of solvent.
Cardboard box with one vial of 10,000 doses (70 ml) and one vial with 500 ml of solvent.
Not all pack sizes may be marketed.
-
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
7. MARKETING AUTHORISATION HOLDER
LABORATORIOS HIPRA, S.A.
Avda. la Selva, 135
17170 Amer (Girona)
SPAIN
Tel.: +34 972 430660
Fax: +34 972 430661
E-mail:
8. MARKETING AUTHORISATION NUMBER(S)
EU/2/16/194/001–003
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Date of first authorisation: 18/04/2016
Date of last renewal: {DD/MM/YYYY}